Related references
Note: Only part of the references are listed.The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification
Herve Nicoloff et al.
NATURE MICROBIOLOGY (2019)
Daptomycin
Mohsen Heidary et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus
Zhuo Ma et al.
PLOS ONE (2018)
Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure
Shuguang Li et al.
FRONTIERS IN MICROBIOLOGY (2017)
Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system
David R. Cameron et al.
SCIENTIFIC REPORTS (2016)
Stepwise Decrease in Daptomycin Susceptibility in Clinical Staphylococcus aureus Isolates Associated with an Initial Mutation in rpoB and a Compensatory Inactivation of the clpX Gene
Kristoffer T. Baek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antimicrobial Heteroresistance: an Emerging Field in Need of Clarity
Omar M. El-Halfawy et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase
X. Li et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus
Viviana Cafiso et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
High-Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It
Jordan R. Smith et al.
CURRENT INFECTIOUS DISEASE REPORTS (2014)
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall
Arnold S. Bayer et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Mechanisms and fitness costs of tigecycline resistance in Escherichia coli
Marius Linkevicius et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
National Surveillance of Methicillin-Resistant Staphylococcus aureus in China Highlights a Still-Evolving Epidemiology with 15 Novel Emerging Multilocus Sequence Types
Meng Xiao et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia
Yu-Yu Chuang et al.
LANCET INFECTIOUS DISEASES (2013)
VraSR Two-Component Regulatory System Contributes to mprF-Mediated Decreased Susceptibility to Daptomycin in In Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus
Shrenik Mehta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
Longzhu Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
Hien M. Nguyen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing
Michael M. Mwangi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus
L Friedman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Share Paper
